For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Seres Therapeutics, Inc.

USPTO Granted Patents = 27

CIPO Patents = 3

EPO Patents = 3

Trademarks = 13

Forward Citations = 457

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

David N Cook (26 out of 29 patents)

Matthew R Henn (24 out of 27 patents)

David Arthur Berry (24 out of 84 patents)

4. John Grant Aunins (22 out of 29 patents)

5. Geoffrey Von Maltzahn (21 out of 101 patents)

6. Kevin Daniel Litcofsky (15 out of 17 patents)

7. Noubar Boghos Afeyan (13 out of 77 patents)

8. Anthony Mario D'Onofrio (12 out of 14 patents)

9. Mary-Jane Lombardo McKenzie (12 out of 13 patents)

10. Gregory McKenzie (9 out of 11 patents)

11. Brian Goodman (9 out of 11 patents)

12. Marin Vulic (8 out of 9 patents)

13. Toshiro Kendrick Ohsumi (8 out of 16 patents)

14. Jonathan Winkler (7 out of 8 patents)

15. Han Zhang (5 out of 5 patents)

27 patents: Sort by Forward Citations

1. 12409197 - Synergistic bacterial compositions and methods of production and use thereof (2025-09-09),

2. 12214002 - Compositions and methods for treating antibiotic resistance (2025-02-04),

3. 12083151 - Synergistic bacterial compositions and methods of production and use thereof (2024-09-10),

4. 11918612 - Synergistic bacterial compositions and methods of production and use thereof (2024-03-05),

5. 11730775 - Methods for treatment of Clostridium difficile infection or recurrence or symptoms thereof (2023-08-22),

6. 11701394 - Compositions and methods for treating cholestatic disease (2023-07-18),

7. 11666612 - Network-based microbial compositions and methods (2023-06-06),

8. 11464812 - Synergistic bacterial compositions and methods of production and use thereof (2022-10-11),

9. 11458174 - Synergistic bacterial compositions and methods of production and use thereof (2022-10-04),

10. 11458173 - Synergistic bacterial compositions and methods of production and use thereof (2022-10-04),

11. 11389490 - Synergistic bacterial compositions and methods of production and use thereof (2022-07-19),

12. 11266699 - Synergistic bacterial compositions and methods of production and use thereof (2022-03-08),

13. 11185562 - Compositions and methods for inhibition of pathogenic bacterial growth (2021-11-30),

14. 10973861 - Compositions and methods (2021-04-13),

15. 10967011 - Compositions and methods (2021-04-06),

Seres Therapeutics, Inc. is a leading biotechnology company focused on developing innovative microbiome therapeutics. The company is dedicated to creating effective solutions for serious diseases using a deep understanding of microbiome science. Seres' cutting-edge research and development efforts aim to harness the power of the human microbiome to transform outcomes for patients in need. For more information, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

27 Patents

#84 in Cambridge, MA

#710 in Massachusetts

#11,985 in US

#23,254 in the World

Cambridge, MA, United States of America

Seres Therapeutics, Inc.

Forward Citations = 457

26 inventors:

David N Cook (26 out of 29 patents)

Matthew R Henn (24 out of 27 patents)

David Arthur Berry (24 out of 84 patents)

4. John Grant Aunins (22 out of 29 patents)

5. Geoffrey Von Maltzahn (21 out of 101 patents)

Please report any incorrect information to support@idiyas.com

Loading…